Tag: Brexit Impact
-
Reeves Signals Higher Taxes on the Wealthy as Part of November Budget Plan
Overview: Reeves frames November budget as a growth-focused plan Chancellor Rachel Reeves has signaled that higher taxes on the UK’s wealthiest could feature in the upcoming November budget, framing the move as part of a broader strategy to repair public finances without returning to austerity. Speaking in Washington at the International Monetary Fund (IMF) meetings,…
-
Brexit’s lasting economic impact shapes Reeves’s tax-raising budget stance
Brexit, the economy, and the budget: Reeves’s framing Labour’s shadow chancellor, Rachel Reeves, has framed Brexit as a central force behind the UK’s stubborn economic challenges, arguing that the decision to leave the European Union has produced a “severe and long lasting” impact on national productivity and living standards. In the same breath, Reeves signalled…
-
UK forecast to be second-fastest growing economy in the G7: IMF outlook explained
UK set for notable growth within the G7, IMF projections show The International Monetary Fund (IMF) has updated its global outlook, placing the United Kingdom as the second-fastest growing economy among the world’s seven most advanced economies this year and next. Growth is forecast at 1.3% in both 2025 and 2026, a modest pace, yet…
-
UK Must Heed Sir John Bell’s Pharma Investment Warning
Understanding the Stakes: Sir John Bell’s Warning Sir John Bell, a prominent figure in the UK’s biotechnology sector, has raised significant concerns over the pharmaceutical industry’s future in the UK. His recent caution follows the announcement that US pharmaceutical giant Merck is scrapping its ambitious £1 billion research center planned for King’s Cross, London. This…
-
Merck Scraps £1 Billion UK Expansion Over Investment Concerns
Overview of Merck’s Decision In a significant blow to the UK pharmaceutical sector, US pharmaceutical giant Merck has announced it will scrap a planned £1 billion expansion of its operations in the United Kingdom. This decision stems from the company’s frustrations regarding insufficient governmental support and investment. As a major player in the global pharmaceutical…